A systematic review of cannabidiol based dosage forms

Abstract

This review article provides a comprehensive overview and analysis of current and experimental cannabidiol (CBD) delivery methods and examines the pharmacological significance of various dosage forms and delivery systems. There are a limited number of CBD-based drugs on the market, many of them utilizing conventional dosage forms, i.e., capsules, oils, creams. The objective of this review is to evaluate various CBD formulations and analyze their formulation, bioavailability, and therapeutic effectiveness. CBD formulations were classified as conventional, transdermal, emulsion, nanoparticle, and miscellaneous. It also provides an exhaustive review of all CBD formulations from research articles, patent publications, and commercial products. In addition, studies data provided by inquiries to contrast new dosage forms with those currently available, like Epidiolex, dronabinol, and various overthe- counter formulations. The expected outcome of this review article is to better inform the scientific community on advancements in delivering CBD, which may improve patient outcomes.